Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical re...

por Hamkour, Safae, van der Heijden, Eefje HM, Lopes, Ana P, Blokland, Sofie L M, Bekker, Cornelis P J, Van Helden-Meeuwsen, Cornelia G, Versnel, Marjan A, Kruize, Aike A, Radstake, Timothy RDJ, Leavis, Helen L, Hillen, Maarten R, van Roon, Joel AG
Publicado 2023